GGrantIndex
← Leaderboards

Jill Gilbert

Louisiana State Univ Hsc New Orleans

$734,194
Attributed
$734,194
Total exposure
14
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $263.7K · FY200506
$500K$375K$250K$125K$0
'05
'06

Funding mix

By agency

NIH$734,194 · 14

By mechanism

P20$398,896 · 2
U10$211,735 · 1
M01$123,563 · 11

Top collaborators

No co-investigators on record.

Most similar at Louisiana State Univ Hsc New Orleans

Same institution · by research overlap

Others in their field

Top investigators on “Human Subject

Research focus

Human SubjectHuman Therapy EvaluationPatient Oriented ResearchClinical ResearchNeoplasm /Cancer Radiation TherapyHead /Neck NeoplasmCombination Cancer TherapySquamous Cell CarcinomaNeoplasm /Cancer ChemotherapyClinical TrialsCommunity Health ServicesCooperative StudyData ManagementDisease /Disorder ModelDrug Screening /EvaluationEarly DiagnosisEnzyme Induction /RepressionHealth Services Research TagLaboratory MouseMass ScreeningMedical Outreach /Case FindingMedical Rehabilitation Related TagMentoring /MentorNeoplasm /Cancer Diagnosis

Grant awards (16)

LSUHSC COBRE: PROJ 1: TOLERANCE MECHANISMS IN HEAD & NECK CANCER$197,595
P20 · FY2006 · RR · contact PI
STUDY OF OSI-774 IN COMBINATION WITH RADIATION THERAPY IN ORAL CAVITY CANCER$17,096
M01 · FY2006 · RR · contact PI
STUDY OF STANDARD DOXORUBICIN AND CYCLOPHOSPHAMIDE IN ADVANCED BREAST CANCER$8,354
M01 · FY2006 · RR · contact PI
PHASE III TRIAL OF CONCURRENT RADIATION AND CHEMOTHERAPY FOR HEAD/NECK CANCER$5,440
M01 · FY2006 · RR · contact PI
CHEMORADIOTHERAPY PLUS C225 (CETUXIMAB) FOR ADVANCED SQUAMOUS CELL CARCINOMA$194
M01 · FY2006 · RR · contact PI
STUDY OF BMS-247550 IN PATIENTS WITH CANCER OF THE HEAD AND NECK$194
M01 · FY2006 · RR · contact PI
LSUHSC COBRE: PROJ 1: TOLERANCE MECHANISMS IN SCCHN$201,301
P20 · FY2005 · RR
PHASE III TRIAL OF CONCURRENT RADIATION AND CHEMOTHERAPY FOR HEAD/NECK CANCER$53,099
M01 · FY2005 · RR
STUDY OF STANDARD DOXORUBICIN AND CYCLOPHOSPHAMIDE IN ADVANCED BREAST CANCER$2,662
M01 · FY2005 · RR
A CLINICAL TRIAL COMPARING THREE COMBINATIONS OF CHEMOTHERAPY IN BREAST CANCER$1,775
M01 · FY2005 · RR
STUDY OF OSI-774 IN COMBINATION WITH RADIATION THERAPY IN ORAL CAVITY CANCER$1,775
M01 · FY2005 · RR
PHASE II TRIAL OF WEEKLY IRINOTECAN AND DOCETAXEL IN RECURRENT HEAD/NECK CANCER$1,627
M01 · FY2005 · RR
TRIAL OF CISPLATIN/ETOPOSIDE/RADIOTHERAPY IN PATIENTS WITH INOPERABLE NSCLC$1,479
M01 · FY2005 · RR
Study of OSI-774 in Combination With Radiation Therapy$29,514
M01 · FY2004 · RR
Phase III Trial of Concurrent Radiation and Chemotherapy for Head/Neck Cancer$354
M01 · FY2004 · RR
LSUHSC Minority Based Community Clinical Oncology$211,735
U10 · FY2002 · CA